Haemonetics (HAE) Tops Q1 EPS by 9c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $75.91 +1.21%
Revenue Growth %: +2.3%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
CRMT, FOMI, FLES, More
Revenue Growth %: +2.3%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $1.10, $0.09 better than the analyst estimate of $1.01. Revenue for the quarter came in at $321.39 million versus the consensus estimate of $302.62 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crude Inventory Fell 3.8 Million Barrels Last Week, Says EIA
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- AMD (AMD) call put ratio 1.4 calls to 1 put as share price down 4.3%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
